Lung Cancer: New Targeted Therapy Options
Italian Agency Approves Encorafenib Combination Therapy for Advanced Lung Cancer with BRAF Mutation A significant advancement in personalized cancer treatment, the Italian Medicines Agency (AIFA) has … Read more